Experienced in Subacute Sclerosing Panencephalitis

Aitor Ballaz

Galdakao, PV, ES 
Experienced in Subacute Sclerosing Panencephalitis
Galdakao, PV, ES 
OverviewLocationsClinical Research

Overview

Aitor Ballaz practices in Galdakao, Spain. Mr. Ballaz is rated as an Experienced expert by MediFind in the treatment of Subacute Sclerosing Panencephalitis. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, and Mesenteric Venous Thrombosis.

His clinical research consists of co-authoring 27 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Subacute Sclerosing Panencephalitis.

Gender
Male

Locations

Galdakao, PV, Spain
Other Locations
Bilbao, PV, Spain
Usansolo, PV, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19
A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Ambrisentan
Study Phase: Phase 2
Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism (PE) in Patients With Unexplained Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial
Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism (PE) in Patients With Unexplained Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: December 01, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

27 Total Publications

Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia.
Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia.
Journal: Clinical chemistry and laboratory medicine
Published: April 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ballaz's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile